Elekta AB Ser. B

Elekta dates back to the 1940’s and is headquartered in Stockholm, Sweden. The company offers solutions in precision radiation medicine for cancer care and brain disorders, combining science, technology and clinical intelligence and treats millions of patients. The company employs around 4,000 people worldwide. Elekta’s areas of expertise include radiotherapy, stereotactic radiosurgery, oncology informatics, neurosurgery, brachytherapy, and particle therapy. Company solutions are focused on targeting the tumor and protecting the patient. In 2019, the company won the Technology Services Industry Association STAR award, which is considered the highest honor in the category of field service. The company’s technology includes solutions such as Elekta IntelliMax, a proactive and increasingly predictive software that predicts and treats problems before they happen and helps reduce unplanned clinical downtime. Elekta is listed on the Nordic Stock Exchange. The company’s financial results for the first quarter of fiscal 2019 include reported gross order intake of SEK 4,390 million, corresponding to a 32% organic growth. Interested in trading this instrument? Follow it for news and updates on the current EKTAB.ST value.